BlackRock Group’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$314K Buy
16,603
+1,155
+7% +$21.8K ﹤0.01% 2505
2016
Q3
$346K Buy
15,448
+1,219
+9% +$27.3K ﹤0.01% 2428
2016
Q2
$254K Sell
14,229
-165
-1% -$2.95K ﹤0.01% 2477
2016
Q1
$197K Buy
14,394
+5,093
+55% +$69.7K ﹤0.01% 2569
2015
Q4
$179K Buy
9,301
+2,541
+38% +$48.9K ﹤0.01% 2537
2015
Q3
$137K Sell
6,760
-1,596
-19% -$32.3K ﹤0.01% 2611
2015
Q2
$277K Buy
+8,356
New +$277K ﹤0.01% 2461
2014
Q2
Sell
-15,502
Closed -$329K 2830
2014
Q1
$329K Buy
+15,502
New +$329K ﹤0.01% 2321